In our study, high MALAT-1 expression levels were associated with low immune cell infiltration (e.g., CD4+ and CD8+ T cells), which may explain the correlation between MALAT-1 and poor prognosis in patients with breast cancer. This evidence concerns the gene MALAT1 and breast carcinoma.